Posted on 8538
Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.
Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant
An estimated 375 adult kidney transplant recipients lose their transplant every year due to a lack of coverage of immunosuppressive medications after the prior 36-month Medicare coverage period.
Congress passes ASN priority legislation to extend immunosuppressive drug coverage for kidney transplant patients. The bipartisan bill is expected to save Medicare $400,000,000 over 10 years by averting the return of transplant patients to dialysis.
The US Senate passed the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act as part of a broad year-end legislative package, extending Medicare coverage of life-saving immunosuppressive medications for the life of the kidney transplant.
Somatus Continues to Advance Kidney Care Model with Addition of Senior Scientific Advisor MCLEAN, Va. (Business Wire) Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.
Highlights
In a survey of adults with kidney failure who were receiving dialysis, most owned mobile devices and had intermediate or advanced mobile health proficiency.
The main reasons for using mobile health were for making appointments, communicating with healthcare personnel, and obtaining laboratory results.
Washington, DC (December 22, 2020) In a survey of adults with kidney failure who were receiving dialysis treatments, most patients were proficient in mobile health and willing to use it. The findings come from an analysis that will appear in an upcoming issue of
CJASN.
Mobile devices, such as smartphones and tablets, can be used by individuals to access their medical information, track and receive reminders of their appointments and medications, and participate in virtual visits with clinicians. In this way, mobile health can provide many benefits for patients, especially for those with complicated care and dietary restrictions.
Kidney Patients Hail U S Senate Move On Transplant Drugs bozemandailychronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bozemandailychronicle.com Daily Mail and Mail on Sunday newspapers.